Please fill out the form below and we will get back to you as soon as possible.
LIXMOX CV 625 is a powerful broad-spectrum antibiotic combination containing Amoxycillin (500 mg) and Potassium Clavulanate (125 mg).
Amoxycillin is a penicillin-type antibiotic that kills bacteria, while Potassium Clavulanate is a beta-lactamase inhibitor that prevents bacteria from defending themselves against the antibiotic. This dual action makes LIXMOX CV 625 highly effective against a wide range of stubborn bacterial infections.
LIXMOX CV 625 is commonly prescribed for:
Respiratory Tract Infections:Acute Sinusitis, Bronchitis, and Community-Acquired Pneumonia.
ENT Infections:Middle ear infections (Otitis Media) and Tonsillitis.
Urinary Tract Infections (UTIs):Cystitis and Urethritis.
Skin and Soft Tissue Infections:Cellulitis, animal bites, and severe dental abscesses.
Bone & Joint Infections:Such as Osteomyelitis.
Enhanced Efficacy:Successfully treats infections caused by bacteria that are resistant to plain Amoxycillin.
Broad Spectrum:Effective against a vast array of both Gram-positive and Gram-negative bacteria.
Rapid Recovery:Quickly reduces the bacterial load in the body, helping patients feel better faster.
Versatility:Trusted by clinicians for various age groups and a wide variety of clinical conditions.
Most side effects are mild and gastrointestinal in nature:
Diarrhea or loose stools
Nausea or vomiting
Indigestion
Skin rash or urticaria
Oral or vaginal yeast infection (thrush)